DNER and prostate cancer: In SPOP-mutant prostate cancer, several dysregulated SPOP substrates (e.g., NCOA3, TRIM24, BET proteins) have been shown to boost the AR pathway leading ultimately to high levels of AR target genes (Supplementary Fig. 4a)3,13,19–26.